• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向腺苷酸环化酶:刺激神经发生及阿尔茨海默病药物治疗的新概念

Targeting Adenylate Cyclase: A Novel Concept for Stimulation of Neurogenesis and Pharmacotherapy of Alzheimer's Disease.

作者信息

Zyuz'kov Gleb Nikolaevich, Miroshnichenko Larisa Arkad Evna, Polykova Tatyana Yur Evna, Simanina Elena Vladislavovna, Chayikovskyi Alexander Vasil Evich

机构信息

Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

出版信息

Cent Nerv Syst Agents Med Chem. 2025;25(2):169-180. doi: 10.2174/0118715249302264240715060630.

DOI:10.2174/0118715249302264240715060630
PMID:39076087
Abstract

BACKGROUND

The low effectiveness of existing pharmacotherapy strategies for Alzheimer's disease (AD) makes it necessary to develop a new concept for the treatment of this type of dementia. This search is promising to be carried out within the framework of the paradigm of targeting intracellular signaling pathways in Regenerative-competent Cells (RCCs).

OBJECTIVES

The purpose of the research is to study the impact of adenylate cyclase (AC) inhibitor on disorders of the psychoemotional status in aged male C57BL/6 mice, as well as on the dynamics of the content and functioning of RCCs nervous tissue.

METHODS

We examined the effect of the AC inhibitor (2',5'-Dideoxyadenosine) on conditioned reflex activity, behavioral and emotional profile in a mouse AD model (16-month-old (aged) male C57BL/6 mice), as well as the functioning of neural stem cells (NSCs), neuronal-committed progenitors (NCPs), and neuroglial cells in the subventricular zone of the cerebral hemispheres (SVZ).

RESULTS

In aged C57BL/6 mice, we found impairments in exploratory behavior, emotional reactivity, and memory, which are the characteristics of senile dementia. Therapy based on AC inhibition led to an increase in the number of NSCs and NPCs in the SVZ due to an increase in their proliferative activity. These changes were more pronounced in NCPs. At the same time, a decrease in the specialization intensity was recorded in NSCs. These phenomena developed against the background of increased secretion of neurotrophic growth factors by oligodendrocytes and microglial cells. The neuroregenerative effects of 2',5'-dideoxyadenosine correlated with the correction of age-related disorders of the psychoemotional status in aged mice.

CONCLUSION

The results provide the basis for the development of targeted drugs based on AC inhibitors to stimulate neurogenesis as an approach for the effective treatment of AD.

摘要

背景

现有治疗阿尔茨海默病(AD)的药物治疗策略效果不佳,因此有必要开发一种治疗此类痴呆症的新概念。有望在有再生能力的细胞(RCCs)中靶向细胞内信号通路的范式框架内进行此项探索。

目的

本研究旨在探讨腺苷酸环化酶(AC)抑制剂对老年雄性C57BL/6小鼠心理情绪状态紊乱的影响,以及对RCCs神经组织含量和功能动态的影响。

方法

我们研究了AC抑制剂(2',5'-二脱氧腺苷)对小鼠AD模型(16月龄雄性C57BL/6小鼠)的条件反射活动、行为和情绪特征的影响,以及对大脑半球脑室下区(SVZ)神经干细胞(NSCs)、神经元定向祖细胞(NCPs)和神经胶质细胞功能的影响。

结果

在老年C57BL/6小鼠中,我们发现其探索行为、情绪反应性和记忆力受损,这些是老年痴呆症的特征。基于AC抑制的治疗导致SVZ中NSCs和NPCs数量增加,这是由于它们的增殖活性增强。这些变化在NCPs中更为明显。同时,记录到NSCs的分化强度降低。这些现象是在少突胶质细胞和小胶质细胞分泌神经营养生长因子增加的背景下发生的。2',5'-二脱氧腺苷的神经再生作用与老年小鼠年龄相关的心理情绪状态紊乱的纠正相关。

结论

这些结果为开发基于AC抑制剂的靶向药物以刺激神经发生作为有效治疗AD的方法提供了依据。

相似文献

1
Targeting Adenylate Cyclase: A Novel Concept for Stimulation of Neurogenesis and Pharmacotherapy of Alzheimer's Disease.靶向腺苷酸环化酶:刺激神经发生及阿尔茨海默病药物治疗的新概念
Cent Nerv Syst Agents Med Chem. 2025;25(2):169-180. doi: 10.2174/0118715249302264240715060630.
2
Nf-κb: A Target for Synchronizing the Functioning Nervous Tissue Progenitors of Different Types in Alzheimer's Disease.核因子-κB:阿尔茨海默病中同步不同类型功能性神经组织祖细胞的靶点。
Curr Mol Pharmacol. 2023;16(2):234-241. doi: 10.2174/1874467215666220601144727.
3
Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.参芍健脑口服液,一种草药配方,通过挽救神经元死亡和触发内源性神经发生,改善由 Aβ42 和东莨菪碱联合诱导的 AD 样小鼠的认知障碍。
J Ethnopharmacol. 2020 Sep 15;259:112957. doi: 10.1016/j.jep.2020.112957. Epub 2020 May 19.
4
Participation of cAMP/PKA-Mediated Signaling Pathways in Functional Activity of Regeneration-Competent Cells in the Nervous Tissue under Conditions of Ethanol-Induced Neurodegeneration.环磷酸腺苷/蛋白激酶A介导的信号通路在乙醇诱导神经退行性变条件下神经组织中具有再生能力的细胞功能活动中的作用
Bull Exp Biol Med. 2019 Oct;167(6):723-727. doi: 10.1007/s10517-019-04608-8. Epub 2019 Oct 26.
5
NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice.神经干细胞促进 APP/PS1 转基因小鼠海马神经发生、代谢变化和突触形成。
Hippocampus. 2017 Dec;27(12):1250-1263. doi: 10.1002/hipo.22794. Epub 2017 Sep 27.
6
Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中,硒代蛋氨酸通过PI3K-Akt-GSK3β-Wnt信号通路促进海马神经发生。
Biochem Biophys Res Commun. 2017 Mar 25;485(1):6-15. doi: 10.1016/j.bbrc.2017.01.069. Epub 2017 Jan 19.
7
Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer's disease.瘦素增强成年神经发生并减少阿尔茨海默病转基因小鼠模型中的病理特征。
Neurobiol Dis. 2021 Jan;148:105219. doi: 10.1016/j.nbd.2020.105219. Epub 2020 Dec 8.
8
Correction of Disorders in Psychoneurological Status and Functioning of Progenitor Cells of the Nervous Tissue with NF-κB Inhibitor under Conditions of Alzheimer's Disease Modeling.在阿尔茨海默病模型条件下,使用 NF-κB 抑制剂纠正神经组织祖细胞的心理神经状态和功能障碍。
Bull Exp Biol Med. 2024 Oct;177(6):725-730. doi: 10.1007/s10517-024-06258-x. Epub 2024 Oct 23.
9
Targeting cAMP-pathway in Regeneration-competent Cells of Nervous Tissue: Potential to Create a Novel Drug for Treatment of Ethanol-induced Neurodegeneration.靶向神经组织中具有再生能力的细胞中的 cAMP 通路:开发新型药物治疗乙醇诱导的神经退行性变的潜力。
Cent Nerv Syst Agents Med Chem. 2021;21(3):172-180. doi: 10.2174/1871524921666210907102847.
10
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's disease.使用阿尔茨海默病的小鼠和人干细胞模型全面描述新型 TrkB 激动剂的神经发生和神经保护作用。
Stem Cell Res Ther. 2024 Jul 6;15(1):200. doi: 10.1186/s13287-024-03818-w.

引用本文的文献

1
Adenylyl Cyclases as Therapeutic Targets in Neuroregeneration.腺苷酸环化酶作为神经再生中的治疗靶点
Int J Mol Sci. 2025 Jun 25;26(13):6081. doi: 10.3390/ijms26136081.

本文引用的文献

1
The Role of cAMP-Dependent Intracellular Signaling Pathways in the Regulation of the Functions of Neural Stem Cells and Neuroglial Cells in Amyloid-β-Induced Neurodegeneration.环磷酸腺苷(cAMP)依赖性细胞内信号通路在淀粉样β蛋白诱导的神经退行性变中对神经干细胞和神经胶质细胞功能调控中的作用
Bull Exp Biol Med. 2023 Aug;175(4):437-441. doi: 10.1007/s10517-023-05881-4. Epub 2023 Sep 28.
2
Alzheimer's disease: From immunotherapy to immunoprevention.阿尔茨海默病:从免疫疗法到免疫预防。
Cell. 2023 Sep 28;186(20):4260-4270. doi: 10.1016/j.cell.2023.08.021. Epub 2023 Sep 19.
3
Targeted Regulation of Intracellular Signal Transduction: A New Paradigm for Stimulation of Neurogenesis in Alzheimer's Disease.
Curr Drug Targets. 2023;24(10):777-780. doi: 10.2174/1389450124666230719104808.
4
Participation of cAMP-Mediated Signaling Transduction in the Regulation of the Secretory Function of Neuroglia during Ethanol-Induced Neurodegeneration.环磷酸腺苷介导的信号转导参与乙醇诱导神经退行性变时神经胶质细胞分泌功能的调节。
Bull Exp Biol Med. 2023 May;175(1):12-16. doi: 10.1007/s10517-023-05800-7. Epub 2023 Jun 20.
5
Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.阿尔茨海默病:疾病病理生理学、生物标志物和疾病修饰药物的新见解和新展望。
Biochem Pharmacol. 2023 May;211:115522. doi: 10.1016/j.bcp.2023.115522. Epub 2023 Mar 28.
6
Mouse and rat ultrasonic vocalizations in neuroscience and neuropharmacology: State of the art and future applications.在神经科学和神经药理学中,鼠类的超声发声:现状与未来应用。
Eur J Neurosci. 2023 Jun;57(12):2062-2096. doi: 10.1111/ejn.15957. Epub 2023 Mar 26.
7
The neuroimmune axis of Alzheimer's disease.阿尔茨海默病的神经免疫轴。
Genome Med. 2023 Jan 26;15(1):6. doi: 10.1186/s13073-023-01155-w.
8
Pathogenesis of Alzheimer's Disease.阿尔茨海默病的发病机制。
Int J Mol Sci. 2022 Dec 21;24(1):107. doi: 10.3390/ijms24010107.
9
Pharmacotherapy Evolution in Alzheimer's Disease: Current Framework and Relevant Directions.阿尔茨海默病药物治疗的演变:当前框架与相关方向。
Cells. 2022 Dec 28;12(1):131. doi: 10.3390/cells12010131.
10
Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs.阿尔茨海默病的分子机制:从治疗靶点到有前途的药物。
Fundam Clin Pharmacol. 2023 Jun;37(3):397-427. doi: 10.1111/fcp.12861. Epub 2023 Jan 13.